Medicare’s current payment system was not designed for modern, software-driven medical technologies. As a result, innovative AI-enabled tools often face unclear or delayed reimbursement — slowing adoption even when the technology is FDA-cleared and clinically valuable.

The Health Tech Investment Act aims to fix that gap by creating a predictable, time-limited Medicare payment pathway for certain algorithm-based healthcare services. This gives patients faster access to innovation while providing providers and developers the clarity needed to invest, deploy, and evaluate new technologies responsibly.